StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis USD 1500M Bond (2.200%, 2020–2030) by Year

USD 1500M Bond (2.200%, 2020–2030) ($M)

Novartis USD 1500M Bond (2.200%, 2020–2030): $1,496M in FY2025, unchanged from a year earlier.

Latest, FY2025
1,496
Period ended Dec 31, 2025
Change on a year earlier
0.0%
1,496 in FY2024
History
6 years
Since FY2020
Sources
5
Documents cited below

Where the FY2025 figure comes from

Source: Novartis Form 20-F (0001114448-26-000004) ↗

Reported in Form 20-F Note 19.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedUSD 1500M Bond (2.200%, 2020–2030) ($M)Year on yearSource
FY2025Dec 31, 20251,4960.0%Novartis Form 20-F (0001114448-26-000004) ↗
FY2024Dec 31, 20241,496+0.1%Novartis Form 20-F (0001114448-26-000004) ↗
FY2023Dec 31, 20231,495+0.1%Novartis Form 20-F (0001370368-25-000004) ↗
FY2022Dec 31, 20221,494+0.1%Novartis Form 20-F (0001370368-24-000004) ↗
FY2021Dec 31, 20211,4930.0%Novartis Form 20-F/A (0001370368-23-000048) ↗
FY2020Dec 31, 20201,493–Novartis Form 20-F (0001370368-22-000010) ↗

Cite this data

StockData. (2026). Novartis USD 1500M Bond (2.200%, 2020–2030) ($M), annual FY2020–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/bond-2-a2-200usd1500million20202030novartiscapita

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.